Company Website: http://karunatx.com
BOSTON -- (Business Wire)

Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that management will present at the following upcoming investor conferences:

Guggenheim 5^th Annual Inflammation & Immunology Conference
Date: Tuesday, November 7, 2023
Time: 1:50 p.m. ET

Stifel 2023 Healthcare Conference
Date: Tuesday, November 14, 2023
Time: 8:35 a.m. ET

A live webcast of the presentations will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcasts will also be archived for up to 30 days on Karuna’s website following the completion of each event.

About Karuna

Karuna Therapeutics is a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by serious mental illness. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples’ lives. For more information, please visit www.karunatx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231101355660/en/

Contacts:

Investors:
Alexis Smith
+1 (617) 352-9917
asmith@karunatx.com

Media:
Julie Ciardiello
+1 (917) 647-0159
julie.ciardiello@karunatx.com

Source: Karuna Therapeutics, Inc.